Vanda Pharmaceuticals reported $5.66M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 2.95M 0.39M
Acorda Therapeutics ACOR:US $ 5.97M 1.77M
Akebia Therapeutics AKBA:US $ 23.02M 19.35M
Alnylam Pharmaceuticals ALNY:US $ 35.63M 2.04M
Anika Therapeutics ANIK:US $ 14.89M 2.8M
AstraZeneca AZN:LN 2279M 790M
Bristol Myers Squibb BMY:US $ 2471M 115M
Clovis Oncology CLVS:US $ 9.41M 0.32M
Eli Lilly And LLY:US $ 2072.1M 21.9M
Esperion Therapeutics ESPR:US $ 7.12M 2.05M
Halozyme Therapeutics HALO:US $ 15.92M 5.66M
Heron Therapeutics HRTX:US $ 11.36M 0.41M
Insmed INSM:US $ 12.19M 1.1M
Intercept Pharmaceuticals ICPT:US $ 0.76M 0.26M
Johnson & Johnson JNJ:US $ 7598M 357M
Ligand Pharmaceuticals LGND:US $ 4.7M 7.28M
Merk MRK:US $ 5334M 1507M
Moderna Inc MRNA:US 1.02B 65M
Novartis NVS:US $ 3755M 245M
Pfizer PFE:US $ 10010M 399M
Ptc Therapeutics PTCT:US $ 10.14M 0.81M
Puma Biotechnology PBYI:US $ 10.84M 1.05M
Takeda 4502:JP Y 308380M 26976M
Teva Pharmaceutical TEVA:IT 1.86B 116M
Ultragenyx Pharmaceutical RARE:US $ 6.1M 2.59M
Vanda Pharmaceuticals VNDA:US $ 5.66M 0.57M
Veracyte VCYT:US $ 23.71M 0.83M